TFS HealthScience

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40014337

Informations générales

Localisation

Sweden

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

23/10/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon 2050

Statut

Targets set

Classification

1.5°C

Année cible

2050

Progression vers l'objectif31%
2015 (année de référence)2050
Description complète des objectifs

Overall Net-Zero Target: TFS HealthScience commits to achieve net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: TFS HealthScience commits to reduce absolute scope 1 GHG emissions 42.0% by 2030 from a 2024 base year. TFS HealthScience also commits to increase active annual sourcing of renewable electricity from 62.0% in 2024 to 100.0% by 2030. TFS HealthScience further commits to reduce scope 3 GHG emissions 51.6% per EUR value added by 2030 from a 2024 base year. Long-Term Targets: TFS HealthScience commits to reduce absolute scope 1 GHG emissions 90.0% by 2050 from a 2024 base year. TFS HealthScience also commits to continue active annual sourcing of 100% renewable electricity from 2030 through 2050. TFS HealthScience further commits to reduce scope 3 GHG emissions 97.0% per EUR value added by 2050 from a 2024 base year.

Net-Zero

Statut

Targets set

Année cible

2050

Progression31%
Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques